2Maeda O, Ando T, Ishiguro K, et al. A patient with esophageal cancer with bone metastasis who achieved pain relief with repetitive adminis- tration of strontium-89 chloride[ J]. Clin J Gastroentero1,2014,7 (5) : 387-391.
4Takasu K, Ogawa K, Nakamura A,et al. Enhanced GABAergic synap- tic transmission at VLPAG neurons and potent modulation by oxycodo- ne in a bone cancer pain model[ J]. Br J Pbarraacol,2015,172(8) : 2148-2164.
5Christensen MH,Petersen LJ,et al. Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review [J]. Cancer Treat Rev,2012,38(2) :164-171.
7Koyyalagunta D, Braera E, Solanki DR, et al. A systematic review of randomized trials on the effeetiveress of opioids for cancer pain[J]. Pain Physician,2012,15 (3) : ES39-58.
8Nakamura A, Hasegawa M, Minami K, et al. Differential activation of theβ-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model[ J]. Br J Pharmaco1,2013, 168(2) :375-388.
9Ono H, Nakamura A, Kanbara T, et al. Effect of the norepinephrine transporter (NET) inhibition on β-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model [J]. J Phammcol Sci, 2014,125(3) :264-273.
10Kucharz J, Filipczak-Bryniarska I, Miehalowska-Kaczmarczyk A, et a- 1. Use of high-dose oxycodone hydrochloride in patients with visceral and nemx)pathie pain[ J]. Contemp Onco1,2015,19 ( 3 ) :257-259.
二级参考文献45
1Paice JA, Ferrell B, The Management of Cancer Pain. CA Cancer J Clin, 2011, 61 : 157 - 182.
2Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 2006, 12 : 6243s - 6249s.
3Delaney A, Fleetwood-Walker SM, Colvin LA, et al. Translational medicine: cancer pain mechanisms and management. Br J Anaesth, 2008, 101 : 87-94.
4Suva L J, Washam C, Richard W, et al. Bone meta- stasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol, 2011, 7 : 208 - 218.
5Luger NM, Mach DB, Sevcik MA, et al. Bone canc- er pain: from model to mechanism to therapy J Pa- in symptom manage, 2005, 29 : S32 - S46.
6Rainsford KD. Anti-inflammatory drugs in the 21 st century. Subcell Biochem, 2007, 42 : 3 - 27.
7Saito O, Aoe T, Yamamoto T. Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminoph- en, and morphine in a mouse model of bone cancer pain. J Anesth, 2005, 19 : 218 - 224.
8McNicol E, Strassels SA, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev, 2005, 1 : 5180.
9King T, Vardanyan A, Majuta L, et al. Morphine treatment accelerates sarcoma-induc-ed bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain, 2007, 132 : 154 - 68.
10Costa L, Lipton A, Coleman RE. Role of Bisphosp- honates for the Mangement of Skeletal Complica- tions and Bone Pain from Skeletal metastases. Suppot Cancer Ther, 2006, 3 : 143 - 153.
